Pharmaceutical stability aspects of nanomedicines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmaceutical stability aspects of nanomedicines

Published:2009-12 Issue:8 Volume:4 Page:857-860
ISSN:1743-5889
Container-title:Nanomedicine
language:en
Short-container-title:Nanomedicine

Author:

Muthu Madaswamy S¹,Feng Si-Shen²

Affiliation:

1. Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi – 221005, India.

2. Department of Chemical & Biomolecular Engineering, National University of Singapore, Block E4, 05-12, Engineering Drive 3, 117576, Singapore

Publisher

Future Medicine Ltd

Subject

Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://www.futuremedicine.com/doi/pdf/10.2217/nnm.09.75

Reference28 articles.

1. ICH Q1A (R2). Stability testing guidelines: stability testing of new drug substances and products. ICH step 5. CPMP/ICH/2736/99.

2. ICH Q1C. Stability testing for new dosage forms. ICH step 5. CPMP/ICH/280/95.

3. Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel

4. Nanoparticles of biodegradable polymers for new-concept chemotherapy

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress and challenges in the translation of cancer nanomedicines;Current Opinion in Biotechnology;2024-02

2. Formulating Resveratrol and Melatonin Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Ocular Administration Using Design of Experiments;Pharmaceutics;2024-01-18

3. Nanotechnology for Novel Drug Delivery: A Systematic Review of Classification, Preparation, Characterization, and Applications of Nanoparticles in Drug Delivery;Biosciences Biotechnology Research Asia;2023-12-31

4. Box Behnken optimization of cubosomes for enhancing the anticancer activity of metformin: Design, characterization, and in-vitro cell proliferation assay on MDA-MB-231 breast and LOVO colon cancer cell lines;International Journal of Pharmaceutics: X;2023-12

5. The challenges to develop antibody-conjugated nanomedicine products;Nano TransMed;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3